Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Severe case 68% Improvement Relative Risk c19early.org/d Al-Anouti et al. Vitamin D for COVID-19 Sufficiency Favors vitamin D Favors control
Associations between Genetic Variants in the Vitamin D Metabolism Pathway and Severity of COVID-19 among UAE Residents
Al-Anouti et al., Nutrients, doi:10.3390/nu13113680
Al-Anouti et al., Associations between Genetic Variants in the Vitamin D Metabolism Pathway and Severity of COVID-19 among UAE.., Nutrients, doi:10.3390/nu13113680
Oct 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 646 COVID-19 patients in the UAE, showing significant associations between genetic determinants of vitamin D metabolism and COVID-19 severity, and an association with vitamin D deficiency and COVID-19 severity. Patients in this study overlap with [AlSafar]. DOH/DQD/2020/538.
risk of severe case, 68.1% lower, RR 0.32, p < 0.001, high D levels 56 of 146 (38.4%), low D levels 52 of 142 (36.6%), adjusted per study, inverted to make RR<1 favor high D levels, odds ratio converted to relative risk, <12ng/ml vs. >20ng/ml.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Al-Anouti et al., 20 Oct 2021, retrospective, United Arab Emirates, peer-reviewed, 11 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: nutrients Article Associations between Genetic Variants in the Vitamin D Metabolism Pathway and Severity of COVID-19 among UAE Residents Fatme Al-Anouti 1,† , Mira Mousa 2,3 , Spyridon N. Karras 4 , William B. Grant 5 , Zainab Alhalwachi 3 , Laila Abdel-Wareth 6,7 , Maimunah Uddin 8 , Nawal Alkaabi 8 , Guan K. Tay 3,9,10 , Bassam Mahboub 11 and Habiba AlSafar 3,12, *,† 1 2 3 4 5 6 7   8 9 Citation: Al-Anouti, F.; Mousa, M.; 10 Karras, S.N.; Grant, W.B.; Alhalwachi, 11 Z.; Abdel-Wareth, L.; Uddin, M.; 12 Alkaabi, N.; Tay, G.K.; Mahboub, B.; et al. Associations between Genetic Variants in the Vitamin D Metabolism * † Department of Health Sciences, College of Natural and Health Sciences, Zayed University, Abu Dhabi, United Arab Emirates; Fatme.AlAnouti@zu.ac.ae Nuffield Department of Women’s and Reproductive Health, Oxford University, Oxford OX1 4BH, UK; mira.mousa@stx.ox.ac.uk Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; zainabhhalwachi@gmail.com (Z.A.); guan.tay@uwa.edu.au (G.K.T.) National Scholarship Foundation, 55535 Thessaloniki, Greece; karraspiros@yahoo.gr Sunlight, Nutrition and Health Research Center, San Francisco, CA 94164-1603, USA; williamgrant08@comcast.net National Reference Laboratory, Abu Dhabi, United Arab Emirates; WarethL@ClevelandClinicAbuDhabi.ae Pathology and Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates Department of Pediatric Infectious Disease, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates; muddin@seha.ae (M.U.); nalkaabi@seha.ae (N.A.) Psychiatry, Medical School, University of Western Australia, Perth, WA 6009, Australia School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA 6027, Australia Dubai Health Authority, Rashid Hospital, Dubai, United Arab Emirates; bhmahboub@dha.gov.ae Department of Biomedical Engineering, College of Engineering, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates Correspondence: habiba.alsafar@ku.ac.ae Both authors contributed equally to this work. Pathway and Severity of COVID-19 among UAE Residents. Nutrients 2021, 13, 3680. https://doi.org/ 10.3390/nu13113680 Academic Editor: Andrea Fabbri Received: 30 September 2021 Accepted: 15 October 2021 Published: 20 October 2021 Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Copyright: © 2021 by the authors. Abstract: Vitamin D has many effects on cells in the immune system. Many studies have linked low vitamin D status with severity of COVID-19. Genetic variants involved in vitamin D metabolism have been implicated as potential risk factors for severe COVID-19 outcomes. This study investigated how genetic variations in humans affected the clinical presentation of COVID-19. In total, 646 patients with SARS-CoV-2 infection were divided into two groups: noncritical COVID-19 (n = 453; 70.12%) and a critical group (n = 193; 29.87%). Genotype data on the GC, NADSYN1, VDR, and CYP2R1 genes along with data on serum 25-hydroxyvitamin D levels were compiled in patients admitted to a major hospital in the United Arab Emirates between April 2020 and January 2021. We identified 12 single-nucleotide polymorphisms associated with the critical COVID-19 condition: rs59241277, rs113574864, rs182901986, rs60349934, and rs113876500; rs4944076, rs4944997, rs4944998, rs4944979, and..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit